Table 5.
Fibre type distribution, fibre area, and capillarisation
| Vitamin C and E group |
Placebo group |
||||||
|---|---|---|---|---|---|---|---|
| Pre | Post | Change, % | Pre | Post | Change, % | P-value | |
| Fibre type 1 (%) | 54 ± 12 | 51 ± 12 | −3.9 ± 22.9 | 49 ± 13 | 44 ± 11 | −7.4 ± 28.5 | 0.124 |
| CSA (μm2) fibre type 1 | 5070 ± 1614 | 5202 ± 1409 | 5.6 ± 22.1 | 5021 ± 1702 | 4893 ± 1206 | 3.7 ± 35.2 | 0.455 |
| CAF fibre type 1 | 4.4 ± 0.9 | 4.4 ± 0.9 | −0.6 ± 13.1 | 4.1 ± 0.8 | 4.2 ± 0.7 | 1.3 ± 13.6 | 0.774 |
| CAFA fibre type 1 | 0.9 ± 0.2 | 0.9 ± 0.2 | −1.6 ± 26.0 | 0.9 ± 0.2 | 0.9 ± 0.3 | 7.0 ± 35.9 | 0.746 |
| CSA (μm2) fibre type 2 | 4831 ± 1646 | 5245 ± 2048 | 11.3 ± 34.3 | 5845 ± 2207 | 6019 ± 2368 | 4.5 ± 34.2 | 0.234 |
| CAF fibre type 2 | 3.8 ± 1.0 | 3.8 ± 1.0 | 3.1 ± 17.1 | 4.0 ± 0.7 | 4.0 ± 0.9 | 0.7 ± 14.4 | 0.730 |
| CAFA fibre type 2 | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.0 ± 30.3 | 0.7 ± 0.2 | 0.8 ± 0.5 | 10.4 ± 57.0 | 0.579 |
Values are mean ± s.d. CAF, capillaries around each fibre; CAFA, CAF/fibre area. *P-value for between-group difference in percentage change.